| #425 Remdesivir and Remdesivir triphosphate | 2: Remdesivir; Remdesivir triphosphate | | | 99.365% | Finished with Errors |
|---|
| #383 Ivermectin 01 | 1: Ivermectin 01 | | | 97.778% | Finished with Errors |
|---|
| #382 Ivermectin | 1: Ivermectin | | | 74.603% | Finished with Errors |
|---|
| #351 DB01222-DB06145-DB09134-DB12865 | 4: DB01222; DB06145; DB12865; DB09134 | | | 99.756% | Finished with Errors |
|---|
| #348 DB00254-DB00511-DB00734-DB00917-DB00997 | 5: DB00254; DB00511; DB00997; DB00734; DB00917 | | | 99.902% | Finished with Errors |
|---|
| #342 ICV832-ICV837 | 5: ICV842; ICV835; ICV837; ICV833; ICV832 | | | 99.415% | Finished with Errors |
|---|
| #308 RG2_VIRAL_3 | 4: LIGAND 137; LIGAND_65; LIGAND 70; LIGAND 40 | | | 95.854% | Finished with Errors |
|---|
| #288 RG2_VIRAL_2 | 5: MOLECULE 127; MOLECULE 25; MOLECULE 78; MOLECULE 177; MOLECULE 20 | | | 91.415% | Finished with Errors |
|---|
| #280 RG_COVID | 2: MOLECULE 78; MOLECULE 20 | | | 97.317% | Finished with Errors |
|---|
| #190 Potential combinationv2 | 4: Proscillaridin; Anidulafungin; Eltrombopag; Imatinib | | | 97.927% | Finished with Errors |
|---|
| #185 Potential combination | 5: Digoxin; Proscillaridin; Anidulafungin; Eltrombopag; Imatinib | | | 98.341% | Finished with Errors |
|---|
| #176 new spider plot | 4: Digoxin; Proscillaridin; Anidulafungin; Eltrombopag | | | 97.805% | Finished with Errors |
|---|
| #174 SARS2v4 | 5: Tetrandrine; Berbamine; Anidulafungin; Gilteritinib; Abemaciclib | | | 98.041% | Finished with Errors |
|---|
| #171 SARS2v1 | 5: Amodiaquine; Cyclosporine; Loperamide; Tilorone; Mefloquine | | | 93.299% | Finished with Errors |
|---|
| #170 Atazanavir Sulfate | 1: Atazanavir Sulfate | | | 99.485% | Finished with Errors |
|---|
| #134 Daclatasvir | 1: Daclatasvir | | | 99.485% | Finished with Errors |
|---|
| #133 Ledipasvir | 1: Ledipasvir | | | 97.938% | Finished with Errors |
|---|
| #132 Voxilaprevir | 1: Voxilaprevir | | | 99.485% | Finished with Errors |
|---|
| #104 4-Drugs-Combination | 4: Saquinavir; Bictegravir; Ledipasvir; Oseltamivir | | | 99.485% | Finished with Errors |
|---|
| #92 LTJv16 | 5: Glecaprevir; Pibrentasvir; Raltegravir; Doravirine; Fosamprenavir | | | 99.381% | Finished with Errors |
|---|
| #90 LTJv14 | 5: Elvitegravir; Daclatasvir; Amantadine; Ritonavir; Tenofovir alafenamide | | | 99.897% | Finished with Errors |
|---|
| #86 LTJv10 | 5: Cidofovir; Efavirenz; Peramivir; Valaciclovir; Velpatasvir | | | 99.278% | Finished with Errors |
|---|
| #85 LTJv9 | 5: Grazoprevir; Tenofovir disoproxil; Asunaprevir; Penciclovir; Voxilaprevir | | | 99.897% | Finished with Errors |
|---|
| #82 LTJv5 | 5: Elbasvir; Famciclovir; Ledipasvir; Ombitasvir; Sofosbuvir | | | 98.763% | Finished with Errors |
|---|
| #79 LTJv3 | 5: Lopinavir; Cobicistat; Lisinopril; Ramipril; Moexipril | | | 99.897% | Finished with Errors |
|---|
| #455 MM_test_1 | 4: MM174; MM173; MM167; MM166 | | | 100.000% | Finished |
|---|
| #452 Remdesivir | 1: Remdesivir | | | 100.000% | Finished |
|---|
| #451 CHEMBL415 | 1: CHEMBL415 | | | 100.000% | Finished |
|---|
| #450 CHEMBL415 | 1: CHEMBL415 | | | 100.000% | Finished |
|---|
| #449 111 | 1: minocycline | | | 100.000% | Finished |
|---|
| #448 Compare 1 | 2: Comp3; Comp2 | | | 100.000% | Finished |
|---|
| #447 Comp1 | 1: Comp1 | | | 100.000% | Finished |
|---|
| #446 benzene | 1: benzene | | | 100.000% | Finished |
|---|
| #445 trial | 2: molecule_mod; molecule | | | 100.000% | Finished |
|---|
| #444 drug | 1: aspirin | | | 100.000% | Finished |
|---|
| #443 wep32 | 4: 4a; 4b; 3b; 4c | | | 100.000% | Finished |
|---|
| #442 wep31 | 5: 4a; 4b; 3b; 4c; 3a | | | 100.000% | Finished |
|---|
| #441 we30 | 5: 4a; 4b; 3b; 4c; 3c | | | 100.000% | Finished |
|---|
| #440 we26 | 3: 2b; 2a; 2c | | | 100.000% | Finished |
|---|
| #439 wep28 | 3: 4a; 4b; 4c | | | 100.000% | Finished |
|---|
| #438 wep27 | 3: 3b; 3a; 3c | | | 100.000% | Finished |
|---|
| #437 me | 1: ddapgme | | | 100.000% | Finished |
|---|
| #436 WEP3 | 5: DDAPG; DDBPG; DDAPGME; DDVPG; DDAPGBENZ | | | 100.000% | Finished |
|---|
| #435 WEP2 | 3: DBPG; DAPG; DVPG | | | 100.000% | Finished |
|---|
| #434 WEP1 | 3: MBPG; MAPG; MVPG | | | 100.000% | Finished |
|---|
| #433 MA | 1: MA | | | 100.000% | Finished |
|---|
| #432 sar | 2: ma; mb | | | 100.000% | Finished |
|---|
| #431 Aspirin | 1: Aspirin | | | 100.000% | Finished |
|---|
| #427 Galidesivir and Tenofovir | 2: Galidesivir; Tenofovir | | | 100.000% | Finished |
|---|
| #426 Galidesivir and Galidesivir triphosphate form 1 | 2: Galidesivir triphosphate form; Galidesivir | | | 100.000% | Finished |
|---|
| #424 Galidesivir and Galidesivir triphosphate form | 2: Galidesivir triphosphate form; Galidesivir | | | 100.000% | Finished |
|---|
| #423 Tenofovir and Galidesivir | 2: Tenofovir; Galidesivir | | | 100.000% | Finished |
|---|
| #422 Galidesivir and Ribavirin | 2: Ribavirin; Galidesivir | | | 100.000% | Finished |
|---|
| #421 Nirmatrelvir and Ritonavir combination | 2: Ritonavir; Nirmatrelvir | | | 100.000% | Finished |
|---|
| #420 Ritonavir | 1: Ritonavir | | | 100.000% | Finished |
|---|
| #419 Nirmatrelvir modification 02 | 2: Nirmatrelvir; Nirmatrelvir Modify 02 | | | 100.000% | Finished |
|---|
| #418 Nirmatrelvir modification | 2: Nirmatrelvir Modify; Nirmatrelvir | | | 100.000% | Finished |
|---|
| #417 Nirmatrelvir | 1: Nirmatrelvir | | | 100.000% | Finished |
|---|
| #416 Yixuan's drug22-virus-ckb2 | 2: Telaprevir; Telaprevir01 | | | 100.000% | Finished |
|---|
| #415 Telaprevir | 1: Telaprevir | | | 100.000% | Finished |
|---|
| #414 Telaprevir | 1: Telaprevir | | | 100.000% | Finished |
|---|
| #413 jj | 1: jj | | | 100.000% | Finished |
|---|
| #412 jj | 1: jj | | | 100.000% | Finished |
|---|
| #411 jj | 1: jj | | | 100.000% | Finished |
|---|
| #410 jjj | 1: jjj | | | 100.000% | Finished |
|---|
| #409 JJJ002 | 1: JJJ002 | | | 100.000% | Finished |
|---|
| #408 Trial JJJ | 1: JJ001 | | | 100.000% | Finished |
|---|
| #407 Trial JJ | 1: sultam1 | | | 100.000% | Finished |
|---|
| #406 Telaprevir | 1: Telaprevir | | | 100.000% | Finished |
|---|
| #405 Telaprevir | 1: Telaprevir | | | 100.000% | Finished |
|---|
| #404 Boceprevir | 1: Boceprevir | | | 100.000% | Finished |
|---|
| #403 Telaprevir | 1: Telaprevir | | | 100.000% | Finished |
|---|
| #396 Edns | 1: Pht | | | 100.000% | Finished |
|---|
| #391 JANZ-2 | 1: erastin | | | 100.000% | Finished |
|---|
| #390 JANZ-erastin | 1: erastin | | | 100.000% | Finished |
|---|
| #389 JANZ-1 | 1: erastin | | | 100.000% | Finished |
|---|
| #387 Drug combination for HCV treatment | 3: Brequinar; Niclosamide; Sofosbuvir | | | 100.000% | Finished |
|---|
| #386 Policresulen | 1: Policresulen | | | 100.000% | Finished |
|---|
| #385 Carnosine | 1: Carnosine | | | 100.000% | Finished |
|---|
| #384 Drug combination for dengue treatment | 2: Sunitinib; Erlotinib | | | 100.000% | Finished |
|---|
| #378 WEP | 5: Pyranojacareubin; Soulattrin; Phylattrin; Inophinnin; Inophinone | | | 100.000% | Finished |
|---|
| #376 wep | 1: C1 | | | 100.000% | Finished |
|---|
| #373 Yixuan's drug11-virus-ckb2 | 4: Remdesivir; Telaprevir; Boceprevir; Narlaprevir | | | 100.000% | Finished |
|---|
| #362 Docking-2 | 1: Resvertrol | | | 100.000% | Finished |
|---|
| #361 docking 1 | 1: baicalein | | | 100.000% | Finished |
|---|
| #360 wep | 3: Naringenin; Luteolin; N3 | | | 100.000% | Finished |
|---|
| #359 sar | 1: pyrazinamide | | | 100.000% | Finished |
|---|
| #358 12121 | 2: 3; 2 | | | 100.000% | Finished |
|---|
| #357 Clase proteomica | 1: Virus T | | | 100.000% | Finished |
|---|
| #356 wep2 | 3: DDAPG; DDBPG; DDVPG | | | 100.000% | Finished |
|---|
| #354 wep | 1: aa | | | 100.000% | Finished |
|---|
| #353 wep | 3: Naringenin; Luteolin; N3 | | | 100.000% | Finished |
|---|
| #350 DB00279-DB00558-DB00800-DB00947-DB01061 | 5: DB00800; DB00558; DB01061; DB00947; DB00279 | | | 100.000% | Finished |
|---|
| #349 DB01211-DB04825-DB09050-DB12839-DB15305 | 5: DB12839; DB01211; DB04825; DB09050; DB15305 | | | 100.000% | Finished |
|---|
| #347 DB01196-DB01380-DB06796-DB09403-DB14650 | 5: DB01380; DB01196; DB09403; DB06796; DB14650 | | | 100.000% | Finished |
|---|
| #346 DB00223-DB00374-DB00663-DB00838-DB00984 | 5: DB00374; DB00984; DB00663; DB00838; DB00223 | | | 100.000% | Finished |
|---|
| #345 DB01092-DB01256-DB06288-DB09164-DB13279 | 5: DB09164; DB01256; DB06288; DB13279; DB01092 | | | 100.000% | Finished |
|---|
| #344 DB00176-DB00367-DB00562-DB00833-DB00955 | 5: DB00176; DB00955; DB00833; DB00367; DB00562 | | | 100.000% | Finished |
|---|
| #343 AAR | 1: Warfarin | | | 100.000% | Finished |
|---|
| #341 ICV827-ICV831 | 5: ICV830; ICV829; ICV827; ICV831; ICV828 | | | 100.000% | Finished |
|---|
| #340 ICV822-ICV826 | 5: ICV822; ICV825; ICV824; ICV823; ICV826 | | | 100.000% | Finished |
|---|
| #339 ICV817-ICV821 | 5: ICV821; ICV817; ICV818; ICV820; ICV819 | | | 100.000% | Finished |
|---|
| #338 ICV812-ICV816 | 5: ICV814; ICV813; ICV816; ICV815; ICV812 | | | 100.000% | Finished |
|---|
| #337 ICV807-ICV811 | 5: ICV807; ICV811; ICV808; ICV809; ICV810 | | | 100.000% | Finished |
|---|
| #336 ICV802-ICV842 | 5: ICV805; ICV804; ICV802; ICV806; ICV803 | | | 100.000% | Finished |
|---|
| #335 TEST | 3: ICV339; ICV346; ICV333 | | | 100.000% | Finished |
|---|
| #334 ICV801 | 1: ICV801 | | | 100.000% | Finished |
|---|
| #333 ICV346 | 1: ICV346 | | | 100.000% | Finished |
|---|
| #332 ICV333 | 1: ICV333 | | | 100.000% | Finished |
|---|
| #331 ICV339 | 1: ICV339 | | | 100.000% | Finished |
|---|
| #330 vc17 | 3: 2 Coumarinate; 3; 2 | | | 100.000% | Finished |
|---|
| #329 drug target | 1: chloroquine | | | 100.000% | Finished |
|---|
| #328 Youshen-test | 1: *** | | | 100.000% | Finished |
|---|
| #327 KK01 | 1: Seed1 | | | 100.000% | Finished |
|---|
| #326 vc1784 | 2: 2 Coumarinate; Agapanthagenin | | | 100.000% | Finished |
|---|
| #325 C MILI.1 | 1: Cordyceps polysaccharide | | | 100.000% | Finished |
|---|
| #316 Project M-ASB-S | 1: Loperamide | | | 100.000% | Finished |
|---|
| #315 Project M-ASB-S | 1: Loperamide | | | 100.000% | Finished |
|---|
| #314 Project M-ASB-S | 1: Loperamide | | | 100.000% | Finished |
|---|
| #313 Project M-ASB-S | 1: Loperamid | | | 100.000% | Finished |
|---|
| #312 Project M-ASB-S | 1: Ribavirin | | | 100.000% | Finished |
|---|
| #311 Project M-ASB-S | 1: Ribavirin | | | 100.000% | Finished |
|---|
| #310 What if | 1: Tetrahydrocannabinol | | | 100.000% | Finished |
|---|
| #307 Aspirin test | 1: Aspirin | | | 100.000% | Finished |
|---|
| #306 Ethane test | 1: Ethane | | | 100.000% | Finished |
|---|
| #305 test | 1: test | | | 100.000% | Finished |
|---|
| #301 Woo test | 1: Aspirin | | | 100.000% | Finished |
|---|
| #287 BIOTEKNOLOGI 2020 | 1: Chloroquine | | | 100.000% | Finished |
|---|
| #281 Darko - curcumin | 1: curcumin | | | 100.000% | Finished |
|---|
| #279 Sarscov_1 | 2: Redemsivir; Cloroquine | | | 100.000% | Finished |
|---|
| #277 VIRUS-CKB | 1: Tanimoto | | | 100.000% | Finished |
|---|
| #276 sample1-SARS-CoV-2/WA6-UW3/human/2020/USA | 1: aspirine | | | 100.000% | Finished |
|---|
| #275 remdesivir | 1: remdesivir | | | 100.000% | Finished |
|---|
| #266 Hydroxychloroquine | 1: Hydroxychloroquine | | | 100.000% | Finished |
|---|
| #260 1 | 3: Tanshinol; Salvianolic acid B; Rutin | | | 100.000% | Finished |
|---|
| #259 1 | 5: Rosmarinic acid; Hyperoside; Quercetin; Luteolin; protocatechuic acid | | | 100.000% | Finished |
|---|
| #258 1 | 5: Ethyl ferulate; Galuteolin; Ferulic acid; Cryptotanshinone; Chlorogenic acid | | | 100.000% | Finished |
|---|
| #257 1 | 5: Albiflorin; Benzoylpaeoniflorin; Apigenin; Caffeic acid; Butylidenephthalide | | | 100.000% | Finished |
|---|
| #256 0 | 5: 3; 5; 4; 2; 1 | | | 100.000% | Finished |
|---|
| #255 0 | 5: 1; 3; 2; 5; 4 | | | 100.000% | Finished |
|---|
| #254 gdsg | 5: ggggg; fdagfh; fghsfhsfh; dfdggg; dfgfgfg | | | 100.000% | Finished |
|---|
| #252 111 | 1: 222 | | | 100.000% | Finished |
|---|
| #251 1 | 1: 1 | | | 100.000% | Finished |
|---|
| #250 ZWJZWJ2 | 1: 5H | | | 100.000% | Finished |
|---|
| #248 ZWJZWJ | 1: Luteolin | | | 100.000% | Finished |
|---|
| #239 Test | 1: Harmony_1 | | | 100.000% | Finished |
|---|
| #238 Compound test | 1: 617 | | | 100.000% | Finished |
|---|
| #237 Remdesivir | 1: *** | | | 100.000% | Finished |
|---|
| #236 Sitagliptin | 1: Sitagliptin | | | 100.000% | Finished |
|---|
| #235 3 drugs | 3: Ebselen; Shikonin; Tideglusib | | | 100.000% | Finished |
|---|
| #232 stat | 1: sta2 | | | 100.000% | Finished |
|---|
| #231 Remdesivir | 1: Remdesivir | | | 100.000% | Finished |
|---|
| #195 ligands in co-crystal | 5: AMP-NSP3; S-Adenosylmethionine-NSP16; SCHEMBL17719237-RDRP; MLN-4760-ACE2; GTPL10716-3CLPro | | | 100.000% | Finished |
|---|
| #194 X3 | 1: X3 | | | 100.000% | Finished |
|---|
| #193 CB2_compounds | 3: WIN55212-2; PY1-61; PY2-64 | | | 100.000% | Finished |
|---|
| #192 p62_compounds_2 | 4: XIE2008; XIE5-2-35; XIE5-2-9; XIE5-2-17 | | | 100.000% | Finished |
|---|
| #191 p62_compounds | 5: XRK3F2; XIE5-1-23; XIE5-2-25; XRK3; XIE106 | | | 100.000% | Finished |
|---|
| #188 New test | 5: Nelfinavir; Conivaptan; Tipranavir; Dihydroergotamine; Eltrombopag | | | 100.000% | Finished |
|---|
| #187 Digoxin+Proscillaridin+Eltrombopag | 3: Digoxin; Proscillaridin; Eltrombopag | | | 100.000% | Finished |
|---|
| #186 Remdesivir+Chloroquine | 2: Remdesivir; Chloroquine | | | 100.000% | Finished |
|---|
| #184 Remdesivirv+Chloroquine | 2: Remdesivirv; Chloroquine | | | 100.000% | Finished |
|---|
| #183 New v2 | 5: Chlorpromazine; Amodiaquine; Amodiaquine hydrochloride; Mefloquine; Imatinib | | | 100.000% | Finished |
|---|
| #182 New v1 | 5: Enisamium iodide; Umifenovir; Ribavirin; Favipiravir; Sofosbuvir | | | 100.000% | Finished |
|---|
| #181 Remdesivirv2 | 3: Remdesivir Nucleoside; Remdesivir; Remdesivir Nucleoside Triphosphate | | | 100.000% | Finished |
|---|
| #180 Remdesivir Nucleoside Triphosphate | 1: Remdesivir Nucleoside Triphosphate | | | 100.000% | Finished |
|---|
| #179 Remdesivir | 1: Remdesivir | | | 100.000% | Finished |
|---|
| #178 hh | 1: hh | | | 100.000% | Finished |
|---|
| #175 SARS2v5 | 4: Bazedoxifene; Ivacaftor; Niclosamide; Eltrombopag | | | 100.000% | Finished |
|---|
| #173 SARS2v3 | 5: Oxyclozanide; Ouabain; Salinomycin; Ciclesonide; Cepharanthine | | | 100.000% | Finished |
|---|
| #172 SARS2v2 | 5: Digoxin; Hexachlorophene; Digitoxin; Proscillaridin; Hydroxyprogesterone caproate | | | 100.000% | Finished |
|---|
| #169 Atazanavir | 1: Atazanavir | | | 100.000% | Finished |
|---|
| #166 lvkui | 1: lvkui | | | 100.000% | Finished |
|---|
| #165 2-17 | 1: 2-17 | | | 100.000% | Finished |
|---|
| #164 5-2-9 | 1: 5-2-9 | | | 100.000% | Finished |
|---|
| #163 melatonin | 1: melatonin | | | 100.000% | Finished |
|---|
| #162 Melatonin | 1: Melatonin | | | 100.000% | Finished |
|---|
| #161 Umifenovir | 1: Umifenovir | | | 100.000% | Finished |
|---|
| #160 Glucocorticoid | 1: Glucocorticoid | | | 100.000% | Finished |
|---|
| #159 Moexipril | 1: Moexipril | | | 100.000% | Finished |
|---|
| #158 Linezolid | 1: Linezolid | | | 100.000% | Finished |
|---|
| #157 Mercaptopurine_melatonin_asiprin | 3: asiprin; Mercaptopurine; melatonin | | | 100.000% | Finished |
|---|
| #156 Dolutegravir/Abacavir/Lamivudine | 3: Lamivudine; Abacavir; Dolutegravir | | | 100.000% | Finished |
|---|
| #155 bictegravir/emtricitabine/tenofovir alafenamide | 3: bictegravir; emtricitabine; tenofovir alafenamide | | | 100.000% | Finished |
|---|
| #137 Jaden-test | 1: sultam | | | 100.000% | Finished |
|---|
| #136 Captopril | 1: Captopril | | | 100.000% | Finished |
|---|
| #135 Lisinopril | 1: Lisinopril | | | 100.000% | Finished |
|---|
| #131 Dolutegravir | 1: Dolutegravir | | | 100.000% | Finished |
|---|
| #130 Saquinavir | 1: Saquinavir | | | 100.000% | Finished |
|---|
| #129 Paritaprevir | 1: Paritaprevir | | | 100.000% | Finished |
|---|
| #128 Bictegravir | 1: Bictegravir | | | 100.000% | Finished |
|---|
| #127 Azithromycin | 1: Azithromycin | | | 100.000% | Finished |
|---|
| #126 ZHIWEI'S TESTING | 1: Remdesivir | | | 100.000% | Finished |
|---|
| #124 Test1 | 1: Test1 | | | 100.000% | Finished |
|---|
| #123 test_too | 1: asprin | | | 100.000% | Finished |
|---|
| #122 5-Drugs | 1: Remdesivir | | | 100.000% | Finished |
|---|
| #121 5-Drugs | 1: Remdesivir | | | 100.000% | Finished |
|---|
| #120 Azithromycin | 1: Azithromycin | | | 100.000% | Finished |
|---|
| #119 5 Drug Combinations | 5: Bictegravir; Paritaprevir; Glimepiride; Fedratinib; Oseltamivir | | | 100.000% | Finished |
|---|
| #118 5-Drug-Combination | 5: Bictegravir; Remdesivir; Glimepiride; Fedratinib; Oseltamivir | | | 100.000% | Finished |
|---|
| #117 5-Drugs | 1: Remdesivir | | | 100.000% | Finished |
|---|
| #116 Diabete | 5: Linagliptin; Acarbose; Glimepiride; Rosiglitazone; Repaglinide | | | 100.000% | Finished |
|---|
| #115 Anti-Inflammatory v3 | 5: Hydrocortisone; Flurandrenolide; Fluticasone propionate; Triamcinolone; Beclomethasone dipropionate | | | 100.000% | Finished |
|---|
| #114 Anti-Inflammatory v2 | 5: Bendazac; Nepafenac; Cortisone acetate; Bromfenac; Flurbiprofen | | | 100.000% | Finished |
|---|
| #113 Anti-Inflammatory v1 | 1: Ketorolac | | | 100.000% | Finished |
|---|
| #112 Hydroxychloroquine | 2: Hydroxychloroquine; Chloroquine | | | 100.000% | Finished |
|---|
| #111 Umifenovir | 1: Umifenovir | | | 100.000% | Finished |
|---|
| #110 Remdesivir | 1: Remdesivir | | | 100.000% | Finished |
|---|
| #106 3-DRUGS | 3: Saquinavir; Bictegravir; Paritaprevir | | | 100.000% | Finished |
|---|
| #105 Drugs Combinations | 4: Saquinavir; Bictegravir; Paritaprevir; Oseltamivir | | | 100.000% | Finished |
|---|
| #103 3-Drugs-Combinations | 3: Saquinavir; Bictegravir; Oseltamivir | | | 100.000% | Finished |
|---|
| #102 Chloro | 1: Chloro | | | 100.000% | Finished |
|---|
| #101 TEST | 1: TEST | | | 100.000% | Finished |
|---|
| #100 LTJv19 | 5: Canagliflozin; Metformin; Glimepiride; Glipizide; Sitagliptin | | | 100.000% | Finished |
|---|
| #99 Danoprevir | 1: Danoprevir | | | 100.000% | Finished |
|---|
| #98 Oseltamivir | 1: Oseltamivir | | | 100.000% | Finished |
|---|
| #97 3-Drugs-Combinations | 3: Saquinavir; Bictegravir; Telaprevir | | | 100.000% | Finished |
|---|
| #93 LTJv17 | 5: 1-deoxymannojirimycin; Etravirine; Amprenavir; Letermovir; Tipranavir | | | 100.000% | Finished |
|---|
| #91 LTJv15 | 5: Zanamivir; Ganciclovir; Acyclovir; Entecavir; Trifluridine | | | 100.000% | Finished |
|---|
| #89 LTJv13 | 5: Abacavir; Dolutegravir; Boceprevir; Ribavirin; Edoxudine | | | 100.000% | Finished |
|---|
| #88 LTJv12 | 5: Saquinavir; Valganciclovir; Nelfinavir; Rilpivirine; Foscarnet | | | 100.000% | Finished |
|---|
| #87 LTJv11 | 5: Indinavir; Lamivudine; Paritaprevir; Delavirdine; Atazanavir | | | 100.000% | Finished |
|---|
| #84 LTJv8 | 5: Dasabuvir; Telaprevir; Idoxuridine; Nevirapine; Rimantadine | | | 100.000% | Finished |
|---|
| #83 LTJv7 | 5: Bictegravir; Darunavir; Baloxavir marboxil; Simeprevir; Adefovir dipivoxil | | | 100.000% | Finished |
|---|
| #81 LTJv5 | 4: Baricitinib; Ruxolitinib; Diclofenac; Fedratinib | | | 100.000% | Finished |
|---|
| #80 LTJv4 | 5: Acetylsalicylic acid; Indomethacin; Ibuprofen; Fenbufen; Ritonavir | | | 100.000% | Finished |
|---|
| #78 LTJv2 | 5: Captopril; zanamivir; Laninamivir; oseltamivir; baloxavir | | | 100.000% | Finished |
|---|
| #77 LTJv1 | 4: Fosinopril; abacavir; Atazanavir; Peramivir | | | 100.000% | Finished |
|---|